First Solar, Inc. (FSLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

PR Newswire

LOS ANGELES, July 29, 2026 /PRNewswire/ — Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against First Solar, Inc. (“First Solar” or the “Company”)(NASDAQ: FSLR).

GPWR

IF YOU SUFFERED A LOSS ON YOUR FIRST SOLAR, INC. (FSLR) INVESTMENTS, CLICK

HERE 

BEFORE AUGUST 24, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT

What Is The Lawsuit About? 
The complaint filed alleges that, between February 26, 2025 and February 24, 2026, Defendants failed to disclose to investors that (1) Defendants had overstated First Solar’s capacity to manage the impact of U.S. tariff policy on the Company’s business; (2) Defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar’s projected performance in the 2026 fiscal year; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

What’s The Next Step? 

Glancy Prongay Wolke & Rotter LLP is a leading national shareholder rights law firm, ready to assist you in potentially pursuing claims to recover your loss.

If you wish to serve as lead plaintiff, you must move the Court no later than August 24, 2026. Please contact us to learn more about your rights and interests by clicking here, by email ([email protected]), or by telephone at 310-201-9150 (Toll-Free: 888-773-9224).

You may retain counsel of your choice. If you bought securities during the class period, you may take no action and remain an absent class member. No class has been certified yet.

Why Glancy Prongay Wolke & Rotter LLP?

GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm’s recent successes, GPWR was named one of Law360’s Securities Groups of the Year and ranked 2nd in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR’s lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR’s past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron’s, Investor’s Business Daily, Forbes, and Money. Prior results do not guarantee a similar outcome.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:

Glancy Prongay Wolke & Rotter LLP,  

1925 Century Park East, Suite 2100,

Los Angeles, CA 90067

Charles Linehan

Email:  [email protected] 

Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/first-solar-inc-fslr-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302838420.html

SOURCE Glancy Prongay Wolke & Rotter LLP

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

PR Newswire

LOS ANGELES, July 29, 2026 /PRNewswire/ — Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against ADMA Biologics, Inc. (“ADMA” or the “Company”)(NASDAQ: ADMA).

GPWR

IF YOU SUFFERED A LOSS ON YOUR ADMA BIOLOGICS, INC. (ADMA) INVESTMENTS, CLICK

HERE 

BEFORE AUGUST 10, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT

What Is The Lawsuit About? 
The complaint filed alleges that, between August 9, 2024 and March 25, 2026, Defendants failed to disclose to investors that (1) ADMA engaged in an undisclosed related party transaction; (2) ADMA used channel stuffing to create an appearance of revenue; (3) ADMA lacked adequate internal controls; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

What’s The Next Step? 

Glancy Prongay Wolke & Rotter LLP is a leading national shareholder rights law firm, ready to assist you in potentially pursuing claims to recover your loss.

If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. Please contact us to learn more about your rights and interests by clicking here, by email ([email protected]), or by telephone at 310-201-9150 (Toll-Free: 888-773-9224).

You may retain counsel of your choice. If you bought securities during the class period, you may take no action and remain an absent class member. No class has been certified yet.

Why Glancy Prongay Wolke & Rotter LLP?

GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm’s recent successes, GPWR was named one of Law360’s Securities Groups of the Year and ranked 2nd in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR’s lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR’s past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron’s, Investor’s Business Daily, Forbes, and Money. Prior results do not guarantee a similar outcome.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:

Glancy Prongay Wolke & Rotter LLP,

1925 Century Park East, Suite 2100,

Los Angeles, CA 90067

Charles Linehan

Email: [email protected] 

Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/adma-biologics-inc-adma-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302838417.html

SOURCE Glancy Prongay Wolke & Rotter LLP

Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas

Commercial Momentum Accelerates as Health System Adopts Turnkey Blood Volume Analysis via CLIA-Certified Send-Out Model

OAK RIDGE, TN, July 29, 2026 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced the launch of a new outpatient Blood Volume Analysis (BVA) program at a leading healthcare facility in eastern Kansas. This initiative expands Daxor’s presence in Midwestern outpatient care, giving regional clinicians direct access to objective volume metrics.

The launch leverages Daxor’s turnkey ezBVA Lab send-out model, enabling outpatient practices to obtain 98% accurate, quantitative blood volume measurements within 24 hours—with zero capital equipment or dedicated lab infrastructure required. By directly measuring total blood, plasma, and red cell volume, clinicians can replace subjective fluid estimation with precise, data-backed decongestion strategies that optimize patient outcomes and prevent readmissions through existing reimbursement structures.

Executive Commentary

“Expanding access to outpatient precision diagnostics is critical to breaking the costly cycle of readmissions. Our turnkey ezBVA Lab service eliminates capital and logistical hurdles, allowing high-volume cardiology centers to seamlessly integrate individualized decongestion care that improves outcomes while lowering overall system costs.”
— Michael Feldschuh, President and CEO of Daxor Corporation

“Relying on clinical estimates for fluid management routinely leaves subclinical hypervolemia unaddressed or leads to over-diuresis. BVA delivers diagnostic accuracy, giving physicians the objective clarity needed to fine-tune therapies, safeguard renal function, and improve opportunities to keep patients safely out of the hospital.”
— John L. Jefferies, MD, MPH, MBA, Chief Medical Officer of Daxor Corporation

About Daxor Corporation

Daxor Corporation (Nasdaq: DXR) is tackling healthcare’s “multi-billion-dollar silent crisis”, the inability to precisely measure blood volume. This often results in suboptimal care, prolonged hospital stays, and increased readmissions for many high-cost medical conditions like heart failure and those requiring ICU care. With 50 years of experience and innovation, Daxor is proud to manufacture and distribute its patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic which offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. This empowers clinicians to make individualized treatment decisions that significantly improve patient outcomes and deliver substantial efficiencies in value-based healthcare. Daxor is ISO certified and operates a U.S.-based, 20,000-square-foot state-of-the-art manufacturing facility, positioning the company for accelerated market expansion.

For more information, please visit our website at Daxor.com.

Sign up to receive news on Daxor’s innovative technology HERE.

Forward-Looking Statements

Certain statements in this release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation statements regarding the impact of hiring sales staff and expansion of our distribution channels. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risks associated with our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, FDA regulatory actions, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and additional other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Daxor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact

Bret Shapiro
COO – Head of Capital Markets
COREIR
516-222-2560
[email protected]|www.coreir.com



Are CBZ, SAFT, NEUP Obtaining Fair Deals for their Shareholders?

PR Newswire


Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.


The proposed transactions may contain terms that could limit superior competing offers.


Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

NEW YORK, July 29, 2026 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

(PRNewsfoto/Halper Sadeh LLP)


CBIZ, Inc. (NYSE: CBZ)’s
 sale to Grant Thornton Advisors LLC for $55.00 in cash per share. If you are a CBIZ shareholder, click here to learn more about your legal rights and options.


Safety Insurance Group Inc. (NASDAQ: SAFT)’s
 sale to an affiliate of Mapfre S.A. for $105.00 per share in cash. If you are a Safety shareholder, click here to learn more about your rights and options.


Neuphoria Therapeutics Inc. (NASDAQ: NEUP)’s
 merger with Scancell Holdings plc. Upon closing of the proposed transaction, Neuphoria shareholders will own 14.5% of the combined company. If you are a Neuphoria shareholder, click here to learn more about your legal rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

One World Trade Center

85th Floor

New York, NY 10007

(212) 763-0060

[email protected]

[email protected] 

https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/are-cbz-saft-neup-obtaining-fair-deals-for-their-shareholders-302838398.html

SOURCE Halper Sadeh LLP

Are D, LEG, NEE, LPSN Obtaining Fair Deals for their Shareholders?

PR Newswire


Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.


The proposed transactions may contain terms that could limit superior competing offers.


Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

NEW YORK, July 29, 2026 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

(PRNewsfoto/Halper Sadeh LLP)


Dominion Energy, Inc. (NYSE: D)’s
 sale to NextEra Energy, Inc. for 0.8138 shares of NextEra for each share of Dominion. If you are a Dominion shareholder, click here to learn more about your legal rights and options.


Leggett & Platt, Incorporated (NYSE: LEG)’s
 sale to Somnigroup International Inc. for 0.1455 shares of Somnigroup common stock for each share of Leggett & Platt common stock. Upon closing of the proposed transaction, Leggett & Platt shareholders will own approximately 9% of the combined company. If you are a Leggett & Platt shareholder, click here to learn more about your legal rights and options.


NextEra Energy, Inc. (NYSE: NEE)’s
 merger with Dominion Energy, Inc. Upon closing of the proposed transaction, NextEra shareholders will own approximately 74.5% of the combined company. If you are a NextEra shareholder, click here to learn more about your rights and options.


LivePerson, Inc. (NASDAQ: LPSN)’s
 sale to SoundHound AI, Inc. for an equity value of $43 million. If you are a LivePerson shareholder, click here to learn more about your rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

One World Trade Center

85th Floor

New York, NY 10007

(212) 763-0060

[email protected]

[email protected] 

https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/are-d-leg-nee-lpsn-obtaining-fair-deals-for-their-shareholders-302838400.html

SOURCE Halper Sadeh LLP

Roblox Deadline: RBLX Investors Have Opportunity to Lead Roblox Corporation Securities Fraud Lawsuit

PR Newswire

NEW YORK, July 29, 2026 /PRNewswire/ — 

Rosen Law Firm Logo

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Roblox Corporation (NYSE: RBLX) between October 31, 2024 and April 30, 2026, inclusive (the “Class Period”), of the important August 7, 2026 lead plaintiff deadline.

So what: If you purchased Roblox common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Roblox class action, go to https://rosenlegal.com/cases/roblox-corporation-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Roblox’s organic growth potential; notably, that Roblox would see a significant slowdown in its growth rates as enrollment in the age verification rollout would quickly taper, compounding the resulting slowdown in on-platform communication, resulting in app store rating reductions and a swift reduction in organic growth. When the true details entered the market, the lawsuit claims that investors suffered damages. 

To join the Roblox class action, go to https://rosenlegal.com/cases/roblox-corporation-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/roblox-deadline-rblx-investors-have-opportunity-to-lead-roblox-corporation-securities-fraud-lawsuit-302838396.html

SOURCE THE ROSEN LAW FIRM, P. A.

Kuehn Law Encourages Investors of Arcus Biosciences, Inc. to Contact Law Firm

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Arcus Biosciences, Inc. (NYSE: RCUS) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you are a long-termRCUS stockholder please contact Sophia Anne Silayan by email at [email protected] or call (833) 672-0814. The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients.Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™  

For additional information, please visit Shareholder Derivative Litigation – Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
[email protected]
(833) 672-0814



Photronics, Inc. (PLAB) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

PR Newswire

LOS ANGELES, July 29, 2026 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with losses related to Photronics, Inc. (“Photronics” or the “Company”)(NASDAQ: PLAB) have opportunity to lead the securities fraud class action lawsuit.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PHOTRONICS, INC. (PLAB), CLICK HERE BEFORE SEPTEMBER 4, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. 

What Is The Lawsuit About?

The complaint filed alleges that, between December 10, 2025 and May 27, 2026, Defendants failed to disclose to investors that (1) the Company’s high-end chip design release pipeline was experiencing severe, ongoing bottlenecks due to elevated foundry utilization rates and equipment cost pressures; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More:

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz, 
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/photronics-inc-plab-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302838393.html

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

Carrier Global Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Carrier Global (CARR)

PR Newswire

Carrier Global’s adjusted earnings per share fell to $0.86 from $0.92 a year earlier and operating margin contracted 1.8 percentage points — and CARR shares sold off immediately after the Q2 2026 earnings release.

NEW YORK, July 29, 2026 /PRNewswire/ — Carrier Global Corp. (NYSE: CARR) shareholders absorbed a sharp post-earnings decline as soon as the Company released its second quarter 2026 results, and an investigation into potential securities law violations is now underway. If you lost money on CARR shares, you are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (888) SueWallSt.

SueWallSt.com

The earnings picture behind the sell-off: adjusted earnings per share came in at $0.86, down from $0.92 in the prior-year period — a 12% year-over-year decline. Operating margin declined 1.8 percentage points over the same span. On the Company’s April 30, 2026 earnings call, Chief Executive Officer David Gitlin had described Carrier’s performance as “financial results that exceeded our expectations.”

The investigation concerns whether Carrier Global’s characterizations of its earnings performance were consistent with the results the Company subsequently reported, and whether investors who purchased CARR shares suffered losses as a result.

Investors who purchased Carrier Global shares and suffered a loss are encouraged to have their losses reviewed at no cost. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the CARR Investigation

Q: Who is eligible to participate in the CARR investigation?A: Investors who purchased Carrier Global Corp. stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Carrier Global made materially false or misleading statements regarding the strength of its earnings performance, including Chief Executive Officer David Gitlin’s April 30, 2026 description of “financial results that exceeded our expectations,” alongside a 12% year-over-year decline in adjusted earnings per share and a 1.8-percentage-point contraction in operating margin.

Q: Who is conducting the CARR investigation?A: Levi & Korsinsky, LLP is investigating potential securities claims on behalf of investors who purchased CARR securities. The firm is nationally recognized, ranked in the ISS Top 50 for seven consecutive years, and has recovered hundreds of millions of dollars for aggrieved investors.

Q: What do CARR investors need to do right now?A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500.

Q: What documents do I need to participate?A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my CARR shares — can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought CARR and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate?A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis — no upfront fees, no retainer, and no out-of-pocket costs.

Q: Do I need to go to court or give testimony?A: No. Participating in the investigation does not require court appearances or depositions.

CONTACT:\

Levi & Korsinsky, LLP\

Joseph E. Levi, Esq.\

33 Whitehall Street, 27th Floor\

New York, NY 10004\

[email protected]\

Tel: (888) SueWallSt\

Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/carrier-global-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-carrier-global-carr-302838391.html

SOURCE SueWallSt.com

MVST Investors Have Opportunity to Lead Microvast Holdings, Inc. Securities Fraud Lawsuit

PR Newswire

NEW YORK, July 29, 2026 /PRNewswire/ — 

Rosen Law Firm Logo

Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Microvast Holdings, Inc. (NASDAQ: MVST) between April 1, 2025 and March 16, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 21, 2026.

So What: If you purchased Microvast securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Microvast class action, go to https://rosenlegal.com/cases/microvast-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 21, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) due to, inter alia, inventory management issues and delays in commercial vehicle rollouts by Microvast’s customers, defendants had overstated Microvast’s ability to reach its margin targets; (2) defendants overstated Microvast’s ability to complete the Huzhou Phase 3.2 expansion by the end of 2025; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Microvast class action, go to https://rosenlegal.com/cases/microvast-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/mvst-investors-have-opportunity-to-lead-microvast-holdings-inc-securities-fraud-lawsuit-302838389.html

SOURCE THE ROSEN LAW FIRM, P. A.